发现现在药企都在卷双_老虎社区_美港股上老虎

发现现在药企都在卷双抗，维立志博这个PD-L1/4-1BB双抗是全球首个进注册临床的4-1BB靶向药，先发已经优势有了

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":444780383171168,"tweetId":"444780383171168","gmtCreate":1749610019172,"gmtModify":1749610020907,"author":{"id":4130491029501360,"idStr":"4130491029501360","authorId":4130491029501360,"authorIdStr":"4130491029501360","name":"甜甜小","avatar":"https://static.tigerbbs.com/25fc231df4362a5cdc318177a8de3233","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body>发现现在药企都在卷双抗，维立志博这个PD-L1/4-1BB双抗是全球首个进注册临床的4-1BB靶向药，先发已经优势有了</body></html>","htmlText":"<html><head></head><body>发现现在药企都在卷双抗，维立志博这个PD-L1/4-1BB双抗是全球首个进注册临床的4-1BB靶向药，先发已经优势有了</body></html>","text":"发现现在药企都在卷双抗，维立志博这个PD-L1/4-1BB双抗是全球首个进注册临床的4-1BB靶向药，先发已经优势有了","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/444780383171168","repostId":0,"isVote":1,"tweetType":1,"viewCount":447,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":100,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/444780383171168"}